Literature DB >> 19922708

Significance of fascin expression in laryngeal squamous cell carcinoma.

A Durmaz1, B Kurt, O Ongoru, S Karahatay, M Gerek, S Yalcin.   

Abstract

OBJECTIVE: Fascin is an actin-binding protein which is expressed in the basal areas of healthy squamous epithelium. Although overexpression of fascin has been shown in many tumours, the relationship between fascin and laryngeal squamous cell carcinoma has not previously been investigated, to the best of our knowledge. This study aimed to investigate the relationship between fascin expression and tumour behaviour in 30 cases of laryngeal squamous cell carcinoma.
MATERIALS AND METHODS: For all lesions, a section of paraffin-embedded tissue was immunohistochemically stained for fascin. The percentage of positive, stained cells was scored from one to five (one = 0-5 per cent, two = 6-25 per cent, three = 26-50 per cent, four = 51-75 per cent and five = 76-100 per cent), and the staining intensity from one to three (one = mild, two = moderate and three = strong). A total immunohistochemical fascin expression score was obtained by multiplying the staining percentage and intensity. The relationship between the total fascin score and each case's age, sex, tumour localisation, tumour-node-metastasis stage and differentiation was evaluated statistically.
RESULTS: Various amounts of fascin expression were observed in all cases. There was a statistically significant relationship between high levels of fascin expression (i.e. a total fascin score of 10 or more) and the cases' tumour stage (p = 0.022), node stage (p = 0.024) and clinical stage (p = 0.014). In addition, worsening tumour differentiation was associated with an increasing fascin score, but this finding was statistically insignificant.
CONCLUSION: These results suggest that laryngeal squamous cell carcinomas with high levels of fascin expression may be more aggressive than those with low expression levels. Further studies with larger series are needed to support these results and to clarify rationales.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922708     DOI: 10.1017/S0022215109991630

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  7 in total

1.  Preliminary proteomic analysis of human serum from patients with laryngeal carcinoma.

Authors:  Hua Zhang; Xicheng Song; Xuexia Liu; Qingquan Zhang; Yan Sun; Xiumei Chen; Chenglu Liu; Yan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-04       Impact factor: 2.503

2.  Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.

Authors:  Ziyun Gao; Qiuhang Zhang; Feng Kong; Ge Chen; Mingchu Li; Hongchuan Guo; Jiantao Liang; Yuhai Bao; Feng Ling
Journal:  Med Oncol       Date:  2012-02-16       Impact factor: 3.064

3.  Fascin as a useful marker for cancer-associated fibroblasts in invasive lung adenocarcinoma.

Authors:  Yuko Yamada; Atsushi Kurata; Koji Fujita; Masahiko Kuroda
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

4.  Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma.

Authors:  Junichiro Sato; Masachika Fujiwara; Tomohiro Kawakami; Ayumi Sumiishi; Seiji Sakata; Atsuhiko Sakamoto; Atsushi Kurata
Journal:  Oncol Lett       Date:  2011-08-17       Impact factor: 2.967

5.  Do immunohistochemical studies have a role in predicting prognosis of laryngeal squamous cell carcinomas? CD44 and Fascin experience.

Authors:  Çiğdem Öztürk; Hüsniye Esra Paşaoğlu; Funda Emre; Ümit Seza Tetikkurt; Tülin Şentürk Ege
Journal:  Acta Biomed       Date:  2022-01-19

Review 6.  The role of fascin-1 in the pathogenesis, diagnosis and management of respiratory related cancers.

Authors:  Naibin Zhang; Yankun Gao; Qiang Bian; Qianqian Wang; Ying Shi; Zhankui Zhao; Honglian Yu
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

7.  Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.

Authors:  Wei Gao; Chunming Zhang; Yan Feng; Ganggang Chen; Shuxin Wen; Hui Huangfu; Binquan Wang
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.